Depression in Dementia or Dementia in Depression? Systematic Review of Studies and Hypotheses.

Alzheimer's disease antidepressants common genes comorbidity dementia depression risk factor.

Journal

Current Alzheimer research
ISSN: 1875-5828
Titre abrégé: Curr Alzheimer Res
Pays: United Arab Emirates
ID NLM: 101208441

Informations de publication

Date de publication:
2020
Historique:
received: 30 07 2019
revised: 09 01 2020
accepted: 18 01 2020
pubmed: 18 2 2020
medline: 8 6 2021
entrez: 18 2 2020
Statut: ppublish

Résumé

The majority of research works to date suggest that Major Depressive Disorder (MDD) is a risk factor for dementia and may predispose to cognitive decline in both early and late onset variants. The presence of depression may not, however, reflect the cause, rather, an effect: it may be a response to cognitive impairment or alters the threshold at which cognitive impairment might manifest or be detected. An alternative hypothesis is that depression may be part of a prodrome to Alzheimer's Disease (AD), suggesting a neurobiological association rather than one of psychological response alone. Genetic polymorphisms may explain some of the variances in shared phenomenology between the diagnoses, the instance, when the conditions arise comorbidly, the order in which they are detected that may depend on individual cognitive and physical reserves, as well as the medical history and individual vulnerability. This hypothesis is biologically sound but has not been systematically investigated to date. The current review highlights how genetic variations are involved in the development of both AD and MDD, and the risk conferred by these variations on the expression of these two disorders comorbidly is an important consideration for future studies of pathoaetiological mechanisms and in the stratification of study samples for randomised controlled trials.

Identifiants

pubmed: 32065103
pii: CAR-EPUB-104552
doi: 10.2174/1567205017666200217104114
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

16-28

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Agnieszka Brzezińska (A)

Department of Old Age Psychiatry and Psychotic Disorders, Medical University of Lodz, Lodz, Poland.

Julius Bourke (J)

Centre for Psychiatry, Wolfson Institute for Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London E14NS, United Kingdom.

Rayito Rivera-Hernández (R)

Department of Psychiatry, Psychology, Legal Medicine and History of Medicine, University of Salamanca, Salamanca, Spain.

Magda Tsolaki (M)

3rd Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece, "George Papanicolaou" Hospital, Thessaloniki, Greece.
Alzheimer Hellas and Central Clinical Hospital of Medical University of Lodz, Lodz, Poland.

Joanna Woźniak (J)

Central Clinical Hospital of Medical University of Lodz, Lodz, Poland.

Jakub Kaźmierski (J)

Department of Old Age Psychiatry and Psychotic Disorders, Medical University of Lodz, Lodz, Poland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH